Molecular Biomarkers in Cancer

Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer, occurrence of cancer, or patient outcome. They may include somatic genetic variants, epigenetic signatures, transcriptional changes and proteomic signatures. These indicators are based on biomolecules, such as nucleic acids and proteins, that can be detected in samples obtained from tissues through tumor biopsy or, more easily and non-invasively, from blood, saliva.

  • Biomolecules
  • Detection technologies
  • Clinical applications of biomarkers
  • Diagnosis and prognosis of Cancer
  • Cancer Medicine

Related Conference of Molecular Biomarkers in Cancer

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Molecular Biomarkers in Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in